Furthermore, both WHO 2022 and ICC 2022 have removed the provisional category of AML with mutated RUNX1, which was present in WHO 2017, due to lack of sufficient evidence supporting its status as a distinct entity. Here, RUNX1 is linked to acute myeloid leukemia.